Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.typeArtigo de periódicopt_BR
dc.title[clinical And Urodynamic Experience With Intravesical Hyaluronic Acid In Painful Bladder Syndrome Associated With Interstitial Cystitis].pt_BR
dc.contributor.authorFigueiredo, A Bpt_BR
dc.contributor.authorPalma, Ppt_BR
dc.contributor.authorRiccetto, Cpt_BR
dc.contributor.authorHerrmann, Vpt_BR
dc.contributor.authorDambros, Mpt_BR
dc.contributor.authorCapmartin, Rpt_BR
unicamp.authorA B Figueiredo, Sección Urología Femenina, División Urología, Facultad de Ciencias Médicas de la Universidade Estadual de Campinas, UNICAMP, Sao Paulo, Brasil.pt_BR Palma,pt Riccetto,pt Herrmann,pt Dambros,pt Capmartin,pt
dc.subjectCystitis, Interstitialpt_BR
dc.subjectHyaluronic Acidpt_BR
dc.subjectMiddle Agedpt_BR
dc.subjectYoung Adultpt_BR
dc.description.abstractfew studies have been carried out on therapeutic options in patients with painful bladder syndrome associated with interstitial cystitis. The aim is to verify the safety and effectiveness of treatment with sodium hyaluronate through intravesical instillation in patients with painful bladder syndrome. a series of 18 female patients is presented, with a mean age of 51 years and prior diagnosis of painful bladder syndrome, who were treated by means of the weekly infusion of an intravesical solution of 40mg of sodium hyaluronate in sterile solution, over a period of eight weeks. The patients were examined clinically and urodynamically prior to their inclusion in the study and eight months after the instillations had concluded. there was a statistically significant improvement in the urodynamic parameters and in the symptoms measured quantitatively by means of the questionnaire Pelvic Pain and Urgency/Frequency between the baseline situation and after the vesical instillation of sodium hyaluronate in patients with painful bladder syndrome. There was no toxicity arising from the treatment, given that no adverse effects were recorded in relation to it. the clinical use of intravesical hyaluronic acid in patients with painful bladder syndrome possibly associated with interstitial cystitis has been demonstrated. The clinical improvement is also associated both with increased bladder capacity and improved bladder sensitivity. Tolerance was excellent. Clinical tests that more profoundly evaluate the therapeutic potential of this drug in this type of patients are required.en
dc.relation.ispartofActas Urologicas Españolaspt_BR
dc.relation.ispartofabbreviationActas Urol Esppt_BR
dc.identifier.citationActas Urologicas Españolas. v. 35, n. 3, p. 184-7, 2011-Mar.pt_BR
dc.rights.holderCopyright © 2010 AEU. Published by Elsevier Espana. All rights reserved.pt_BR
dc.description.provenanceMade available in DSpace on 2015-11-27T13:21:10Z (GMT). No. of bitstreams: 1 pmed_21397161.pdf: 84630 bytes, checksum: a2e4bdeb8d79452d5717748a59839249 (MD5) Previous issue date: 2011en
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File SizeFormat 
pmed_21397161.pdf82.65 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.